IKZF1 and IKZF3 are two transcription factors that play a critical role in MM progression [128], and it is not surprising that CRBN modulation via IMiBs is being validated as a tool for the treatment of MM. The gene discussed is IKZF3; the disease is Miyoshi myopathy.